Furthermore, the patients in group B showed a significant improvement in insulin sensitivity and a reduction in anthropometric parameters compared with the patients in group A. In a study involving 46 adults with NAFLD, the effect of a clinical intervention and a diet based on MD lasting 6 months was evaluated [27]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.